GFG Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$868K Buy
724
+7
+1% +$7.15K 0.24% 53
2026
Q1
$659K Buy
717
+624
+671% +$633K 0.21% 55
2025
Q4
$99.9K Buy
+93
New +$88.9K 0.04% 63
2025
Q3
Sell
-84
Closed -$65.5K 216
2025
Q2
$65.5K Sell
84
-640
-88% -$497K 0.02% 94
2025
Q1
$598K Buy
724
+415
+134% +$345K 0.18% 63
2024
Q4
$239K Buy
+309
New +$256K 0.06% 98

Other funds holding LLY

GFG Capital's LLY Position: Q2 2026 in Review

GFG Capital increased its Eli Lilly (LLY) stake by 0.98% in Q2 2026, buying an estimated $7.15K and bringing the position to 724 shares worth $868K. The position accounts for 0.24% of the portfolio, ranked #53.

GFG Capital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 1,011 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GFG Capital held 724 shares of Eli Lilly worth $868K as of Q2 2026.
  • GFG Capital bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.24% of GFG Capital's portfolio in Q2 2026, its #53 holding.
  • GFG Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 1,011 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GFG Capital's 13F filing for Q2 2026, filed 20 Jul 2026.